⚙ PAGE STYLES + THANK-YOU SCRIPT — hidden on the live page. Edit fonts/colors in each widget; edit shared rules here.
Free provider briefing
Can You Prescribe These Peptides Yet?
Here's Where Things Stand.
James LaValle, RPh, CCN, explains where the FDA committee vote stands, what still has to happen before any of these peptides become eligible for compounding, and how to evaluate a peptide source.
Why this matters
The vote made headlines.
The details decide what you can actually do.
- Six peptides were recommended for the Category 1 bulk substances list. One reviewed alongside them was not.
- Inclusion is decided peptide by peptide, not as a category.
- A committee recommendation is not a final rule. FDA and HHS rulemaking still has to follow.
- Sourcing and testing matter as much as the molecule: identity, contaminants, and registered API suppliers.
Download the briefing
Get the 10 takeaways
before the final rule lands.
Enter your details and we’ll send the PDF straight to your inbox.
- Which six peptides were recommended — and the one that wasn't
- Why this is a recommendation, not a rule, and what still has to happen
- What the committee actually weighed (it isn't a clinical trial standard)
- What to look for on a for-human-use certificate of assay
- By submitting you agree to receive educational emails from Southend Pharmacy. Unsubscribe anytime. We never share your information.
About the speaker
“Inclusion is evaluated peptide by peptide, not as a category.”
Dr. James LaValle
B.S.Pharm, CCN, MT, DHM, DHPh
Guest speaker at Southend Pharmacy’s educational provider webinar, The Current State of Peptides.
Our Coverage
Southend Pharmacy Supports Providers Across 40+ States And Growing
Interactive map, updated real-time and monitored by our team during expansion
Active state
Not Active State
Tap to close
Trusted by 9600+ Providers to date.
|
Updated: 12:18PM CDT 10-12-26
40
States Covered
55K
SQ FT Facility
Centrally located Houston, TX
280M
Patients Reachable
*Total population in covered states
76%
US Population
Check your inbox
Your briefing is on its way.
Or grab it right here.
If it isn’t there in a couple of minutes, check your spam or promotions folder.
Want the full webinar with Dr. LaValle?
